The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
chicken lol No1 it only costs 9 squids to trade ABCM and abcm might be just taken over + plus the NDAQ is down so much its got to be worth a punt, have a good as the saying goes lol.
True, couldn’t find their charges . Suspect they are reasonable though. The ft are talking about M&As dropping off but with the SP of many good companies down I think there may well be some raids happening in the first quarter of 2023. Just my thoughts.
Ive also decided not to invest overseas as I don’t want to take on the extra risk with foreign ex movements. :-).
thhey have still have FCA protection
Trading 212 us to be called Avus which was run by 2 Bulgarians. Who ceased directorships . Trading 212 operate out of Bulgaria and Cyprus. They are probably ok but the mention of Bulgaria and Cyprus put me right off. ;-).
AJ bell. I use to use Bestinvest but they are rubbish. Although they didn’t charge to switch funds. Finding AJ bell quite good so far. Also been leaning towards trackers but it’s all a it of a guessing game as fund managers seem to be in a lot of cases lucky than experts. :-)
No 1 what trading program do you use? I have been looking @trading 212 what do you think???
Many thanks Denby.
I’ve been treading water for about 3 months now but paper loss not to bad . Just have to wait for individual stocks to rise at some point. Bought / sold/ bought LG mainly for the div. Also adding my gsk as I think they will prove good in Time! . Darktrace I’m hoping will give out good figures in Jan . :-).
HI MATE .
you need to download and fill in a W-8BEN FORM SO YOU DONT GET TAX usa.
I am happy to confirm that we have received and processed your W-8BEN form and this is now registered against the account details provided.
The W-8BEN form is valid for three calendar years after you sign it, unless your personal circumstances change. Please let us know within 30 days if this happens. We will contact you when your form is due to expire.
Yours sincerely,
Customer Registration Team
Why can’t we hang on to good companies like Abcam and Arm. How will this effect tax as it’s listed in USA If I buy after 14 dec. :-(.
got a few to day near the bottom just another dollar down and think we might be at the bottom.
I believe that this will be taken over and I am still buying I only have 7.6k shares.
The delisting, I think happens on 14 December. I have bought another decent tranche of shares today to double my holding. Time will determine the wisdom or folly.
ABC are not doing very well since the move to the states in full
As the Fed has hinted that interest rates will not be as aggressive as in the past with the next rise close to a 0.5% increase, markets have responded positively, particularly the NASDAQ today. And although I am conscious that many retail investors like to believe that their portfolio is diverse, geographic exposure provides depth. Sure, for many AIM can seem a little wild, but compared with the NASDAQ is a lamb.
Fortunately ABC is already listed across the swamp. Perhaps the only real differences seen by holders based in UK (and Europe) will be in dealing times that do not correspond with London and fewer contributions here.
Alas_Smith,SussexEngineer. the last week T sold my entire holding in ABC, FOR 1466. and bought back in @ 1250 + I Increased my holding by a third . I go with the BOD on their decision, to move to a single listing in the states my personal view this can only be good for ABC. ABC might even be taken over, but I hope not.
Although I am not in the least qualified to provide advice and certainly would not criticise anothers decision, I will caution others with, I hope, a reasoned and broad response.
The most influential economy in the world is US. The largest companies by MCap are in the US and the dollar is the rate against which every commodity is priced. In other words, just because it is dealt in, based in or trades from USA means that it is a bit more important than all the other exchanges in the World. Sure, London is right up there, so is Paris, Frankfurt, Melbourne and Tokyo but as economies go, US then China, India, Europe etc down the pecking order.
FWIW, my portfolio from 1979 until 2008 was entirely UK specific (I knew nothing else and considered nothing beyond UK shores). Around 60% portfolio is US/China based these days and although down a long way this year (-22.x%), recovery when this bear market is over is likely to be greater than if there was a concentration in a single market.
Good fortune to all. 2023 has more turbulence ahead as I foresee OPEC cutting production to deepen recession for UK. Another thought to consider different geographic sector to place investment deposits.
Shame that management have moved the share dealings solely to the States, when 90% are on the LSE. I decided to pull my shares on the back of this.
I agree it a great business, well run with a fantastic future but in the short term plenty of long term holders like me will have pulled the plug.
Alas_Smith I do think that your views about ABC are spot on. It still seems to expanding with all the head winds that are around at the moment, it just seems a bit over done with a drop of 13.50% just due to share sales, share shifting by fund managers. this company is well run and as you said have excellent management. just think is this is well over done.
I believe it is all part and parcel of those funds re-arranging their holdings. As the underlying business is good and the managers excellent, I am not in the least fussed with what is, to all intents and purpose, noise.
This is just Carnage for Abcam
To good to be true yesterday back down
this will keep going until she goes over
With shares only having a single listing once cancelled, my only concern in the short term is in regards to fund managers moving holdings between portfolio’s in their ****nal to bring volatility. Long term should be better and not tarnished with any reputational damage that AIM might have for investors.
NanoString Technologies (NASDAQ:NSTG) and Abcam (NASDAQ:ABCM) said they expanded their collaboration to advance spatial multiomics research.
Under the agreement, the companies will co-market Abcam antibodies for NanoString's high-plex spatial multiomic solutions.
Abcam RabMAb recombinant antibodies will be commercialized as part of the first 64-plex protein panel for NanoString's CosMx Spatial Molecular Imager (SMI).
"This relationship will further expand the depth and breadth of spatial biology offerings on NanoString instrumentation into new frontiers of human biology down to single-cell resolution— a true revolution in the spatial biology field," said NanoString President and CEO Brad Gray.
MIGHT come in again when we get to 1290-1300